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Abstract
Neurofibromin is one of the few Ras-GTP activating proteins (Ras-GAPs) 
expressed in the brain. Disruption of its expression leads to the detrimental disease 
neurofibromatosis type 1 (NF1). Many studies have revealed the crucial role of 
NF1 in developing and adult tissues. However, these studies have focused on the 
expression of the entire NF1 gene and largely ignored the role of an alternative 
splicing event that controls the Ras-GAP function of neurofibromin. The focus of 
this chapter is NF1 exon 23a. This exon is located in the GAP-related domain (GRD) 
of neurofibromin. Its expression level, indicated by the percentage of its inclusion 
in the NF1 mRNA transcripts, has a profound effect on the Ras-GAP function of 
neurofibromin. In this chapter, we review the expression pattern of exon 23a and 
the molecular mechanisms that regulate its expression. We then discuss the role 
of its expression in Ras/ERK signaling and learning behaviors in mice. Lastly, we 
propose a few directions for future studies.
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1. Introduction
Neurofibromatosis type 1 (NF1) is a genetic disorder that affects approximately 1 
in 2000–4000 individuals [1]. The disease hallmark includes tumors in the nervous 
system, most commonly, benign peripheral nerve tumors or neurofibromas, and 
café-au-lait macules [1]. In addition, many NF1 patients exhibit cognitive and 
behavioral problems, bone abnormalities and hypertension [1].
The underlying cause of the NF1 disease is the germline mutation in one of the 
two alleles of the NF1 gene on chromosome 17q11.2. This gene, spanning more than 
350 kilobases (kb) of genomic DNA, codes for neurofibromin, which is one of the 
major GTPase activating proteins (GAPs) that down regulates the activity of Ras 
[2–5]. Neurofibromin attenuates Ras signaling by converting it from its active GTP-
bound form to its inactive GDP-bound state via the GAP-related domain (GRD). 
Mutations in the NF1 gene reduce/abolish the Ras-GAP function of neurofibromin, 
which leads to abnormally high cellular activity of the Ras signaling pathway [4, 5].
Proper expression of the GRD is critical to achieving the optimal Ras-GAP function 
of neurofibromin. In mammals, the NF1 gene expression is highly regulated tempo-
rally and spatially. During embryonic development, NF1 is expressed in many tissues. 
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However, in adults, its expression is highly enriched in the nervous system in neurons, 
oligodendrocytes and Schwann cells [6–8]. A recent study demonstrated that in both 
mouse and human brain, NF1 expression is enriched in inhibitory neurons [9].
In addition to transcriptional regulation, the expression output of the NF1 gene 
is subject to a post-transcriptional alternative splicing regulation that gives rise to 
two distinct NF1 transcripts: one with and the other without exon 23a (exon 31 in 
the current NF1 nomenclature) [10]. Exon 23a is a 63 nucleotide in-frame cassette 
exon that, when translated, adds additional 21 amino acids in the neurofibromin 
protein [10]. The neurofibromin that does not contain the 21 amino acids is named 
type 1 isoform whereas the protein that contains the extra amino acids is named 
type 2 isoform (Figure 1) [10]. Because these additional amino acids are located in 
the GRD, it was immediately suspected when exon 23a was identified that inclu-
sion of these amino acids would affect the Ras-GAP function of neurofibromin. As 
predicted, early in vitro analysis using truncated GRD expression plasmids with 
or without exon 23a demonstrated that the GRD polypeptide containing exon 23a 
showed up to 10 times lower Ras-GAP activity than that the GRD without exon 23a 
[10, 11]. For more than a decade after these initial studies, it remained unknown if 
expression of this alternative exon regulates the full-length neurofibromin protein 
in a similar fashion. Since 2002, our group has conducted extensive research to 
understand the biology of this alternative splicing event.
In this chapter, we will focus on exon 23a and discuss the following questions. 
What is the expression pattern of this exon? How is its expression regulated? How 
does its expression affect the Ras-GAP function of neurofibromin? How does its 
expression affect the signaling pathways downstream of Ras? How does disruption 
of its expression affect animal behaviors in vivo? Lastly, we will discuss the pressing 
remaining questions for future studies.
2. The functional role of regulated expression of NF1 exon 23a
2.1 Expression of Nf1 exon 23a in mouse
RT-PCR analysis indicated that the alternative inclusion of exon 23a is tightly 
regulated in tissue- and developmental stage-specific patterns. In adults, exon 23a 
Figure 1. 
A diagram showing that alternative splicing of the NF1/Nf1 exon 23a can give rise two isoforms of 
neurofibromin. Early in vitro experiments demonstrated that inclusion of exon 23a leads to reduced Ras-GAP 
activity of neurofibromin and thus increased active Ras activity. The two protein isoforms are depicted above 
and below and pre-mRNA in the middle. The diagram is not drawn to scale.
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is predominantly skipped in the brain and testis leading to production of the type 1 
NF1 isoform, while in other tissues, exon 23a is included to various extents leading 
to production of the type 2 isoform [6, 12, 13]. In adult mouse, exon 23a is included 
at 8% in the testis, 11% in the brain, 42% in the spleen, 58% in the heart, 62% in the 
liver, 78% in the kidney and 82% in the lung [14]. Within the brain, exon 23a is least 
included in hippocampus at 2–4% and slightly more included in the cortex at 10% 
[15]. In primary mouse cardiomyocytes, exon 23a is included at 70% [16].
During development, in the mouse brain, a switch from the isoform 2 to isoform 
1 occurs during early embryonic development between day E10 and E11 [6, 13]. The 
biological significance of this switch has not been investigated.
2.2 Molecular mechanisms regulating alternative splicing of exon 23a
Most of our experiments were conducted using human NF1 sequence and 
human, mouse or rat cells. All of the existing evidences indicate that this alternative 
splicing event is conserved in mammalian cells [17]. Consistent with the widely 
used nomenclature, the human gene is designated as NF1 while the mouse gene is 
designated as Nf1 throughout the chapter.
The differential splicing of exon 23a is under complex control by two distinct 
mechanisms (Figure 2). The first mechanism involves several regulatory RNA-binding 
proteins (RBPs) which promote either its skipping or inclusion (Figure 2A). Two 
families of RBPs which promote the skipping of exon 23a have been identified, Hu pro-
teins, also known as ELAV-like proteins, and CUG-BP1 and ETR-3 like factors (CELF). 
Hu proteins bind to AU-rich regions of RNA both upstream and downstream of exon 
23a while CELF proteins bind to UG-rich motifs upstream of exon 23a (Figure 2A) 
[18–20]. Mechanistically, upstream of exon 23a, Hu and CELF proteins function to 
block the splicing factor U2AF from binding to the 3′ splice site, while downstream of 
exon 23a, Hu proteins block splicing factors U1 and U6 snRNP complexes from bind-
ing to the 5′ splicing site [18, 20]. Two additional families of RBPs, TIA-1/TIAR and 
muscleblind-like (MBNL) proteins, on the other hand, promote the inclusion of exon 
23a (Figure 2A). TIA-1/TIAR proteins, in direct competition for binding with Hu 
proteins, bind to the U-rich sequence downstream of exon 23a, promoting the U1 and 
U6 snRNP binding at the 5′ splice site and inclusion of the exon [18]. MBNL proteins 
binds to a sequence upstream of exon 23a to promote its inclusion (Figure 2A) [21].
The second mechanism involves epigenetic regulation of alternative splicing, 
at the chromatin level, through altering histone modifications and transcriptional 
elongation rate (Figure 2B). One of the models that explains the epigenetic regula-
tion of splicing is the kinetics coupling model of transcription and splicing [22]. 
This model predicts that faster transcriptional elongation rate of RNAPII promotes 
skipping of an alternative exon, which is usually surrounded by suboptimal splicing 
signals, as in the case of NF1 exon 23a [23]. One of the factors regulating transcrip-
tional elongation rate is the “openness” of chromatin modulated by histone acetyla-
tion [22]. The higher level of histone acetylation is correlated with more relaxed 
configuration of the chromatin, which allows RNAPII move faster during tran-
scription. Exon 23a is subjected to this mode of regulation in two different ways as 
shown in Figure 2B. Studies using mouse primary cardiomyocytes where exon 23a 
is normally included at 70% demonstrated that an increase in Ca2+ by KCl-induced 
depolarization led to a significant reduction of inclusion to 10–15% through 
increasing histone acetylation on the body of the entire Nf1 gene [16]. In neuronal 
cells, Hu proteins interact with HDAC2, a member of the histone deacetylase family, 
that reduces the deacetylation enzymatic activity of HDAC2 in a localized fashion 
[24]. In both cases, the transcriptional elongation rate is increased by histone 
hyperacetylation, leading to exon 23a skipping [16, 24].
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2.3 Role of exon 23a expression in cell signaling regulation
In order to uncover the biological importance of exon 23a inclusion, our 
laboratory generated mutant embryonic stem (ES) cell lines through the classical 
gene-targeting knock-in approach [23]. We generated two contrasting mouse ES 
cell lines, one showing 100% exon 23a inclusion in the endogenously expressed Nf1 
gene, Nf123aIN/23aIN, and the other 100% exon 23a skipping, Nf123aΔ/23aΔ [23].
We then differentiated these ES cells into CNS-like neurons following an estab-
lished protocol [25]. In this two week procedure, mouse ES cells were first grown 
in a non-adherent dish in the presence of retinoic acid to form cellular aggregates, 
which were then dissociated and plated on laminin-coated tissue culture plates 
in neuronal culture medium that support neural differentiation and maturation. 
This procedure was shown to produce pyramidal neurons with >90% homogene-
ity [25]. When the two mutant Nf1 ES cell lines were differentiated into neuronal 
cells, they showed drastically different Ras signaling but similar cAMP activities 
[23]. Compared to wild type neurons (10%, exon 23a inclusion), the Nf123aΔ/23aΔ 
neurons (0% exon 23a inclusion) exhibited a slightly lower level of Ras-GTP while 
the Nf123aIN/23aIN neurons (100% exon 23a inclusion) exhibited at least three times 
more Ras-GTP [23]. These experiments establish that exon 23a expression affects 
the Ras-GAP function of the endogenously expressed neurofibromin. Interestingly, 
Figure 2. 
Regulation of alternative splicing of NF1/Nf1 exon 23a. A. RBP-mediated regulatory mechanisms. TIA and 
MBNL proteins promote inclusion of exon 23a by recruiting splicing factors U1 and U6 to the 5′ splice site and 
U2AF to the 3′ splice site, respectively. Hu and CELF proteins promote skipping of exon 23a by preventing these 
splicing factors from binding. B. Epigenetic regulatory mechanisms. Both mechanisms involve increased histone 
acetylation, which leads to increased transcription elongation rate causing exon 23a to be skipped. The increased 
histone acetylation is triggered by either nuclear export of HDAC proteins (box 1) or decreased activity of 
HDAC2 (box 2). The up and down arrows indicate increase and decrease, respectively.
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Nf1 exon 23a expression specifically affects the phospho-ERK1/2 level downstream 
of Ras but not the PI3K/Akt/mTOR pathway [23].
Using the Nf123aIN/23aIN ES cells, we generated a mutant mouse line [14]. The 
NF123aIN/+ mouse ES cells were from the 129 background. Chimeric 129:C57Bl/6 J 
mice were generated by blastocyst injection of the Nf123aIN/+ ES cells and crossed 
with C57Bl/6 J mice. A founding Nf123aIN/+ mouse was obtained. The mice were then 
crossed for 10 generations onto the C57Bl/6 J background. In the Nf123aIN/23aIN mice, 
the Nf1 gene only produces the isoform II neurofibromin where exon 23a is included 
in all cell types at 100% [14]. When the mouse brain proteins were analyzed, 
similar results were found as in the ES-derived neurons. While Ras-GTP level was 
barely detectable in the wild type mouse brain, it was significantly increased in the 
Nf123aIN/23aIN brain [14]. The pERK1/2 is six times higher in the mutant than wild 
type brain while the PI3K/Akt/mTOR pathway was unaltered [14]. These findings 
support a model in which alternative splicing of exon 23a plays a crucial role in 
regulating the Ras–Raf–MEK–ERK signaling pathway in vivo.
2.4 Role of exon 23a expression in mouse learning and memory behaviors
To explore the link between exon 23a regulation of Ras and cognitive behaviors, 
a battery of learning and memory tests were conducted comparing the wildtype and 
mutant Nf123aIN/23aIN mice. The results of these tests indicated clear impairments in 
learning and memory performance in the mutant mice [14].
To test short-term and long-term spatial memory, a T-maze and Morris 
water maze test were conducted, respectively. T-maze test is used to examine the 
short-term spatial memory. In this test, mice were placed in a T-shaped maze and 
allowed to explore the maze freely for 10 minutes while one of the arms was closed. 
Following the exploration, mice were returned to their home cage for 2 hours and 
then put back in the T-maze with all three arms open. Once put in the T-maze, mice 
were video recorded. The memory measurement was calculated as the time spent 
in the previously closed arm divided by the overall time spent in both arms, which 
was expected to be 50% by chance. The wild type mice were more likely to explore 
an unfamiliar lever arm than a familiar one, a preference indicative of an active 
short-term memory. The mutant Nf123aIN/23aIN mice showed an impairment of this 
function and failed to display any preference between lever arms, with a selection 
rate around 50% [14].
Morris water maze test is used to examine the long-term spatial memory. In this 
test, mice were trained in a small water pool in a well-lit room replete of visual cues. 
A hidden escape platform was placed 0.5 cm beneath the water level in a particular 
location in the pool. Animals were tested for three trials per day over 4 days. For 
these trials, mice were placed in the water and allowed to swim for 60 seconds. If 
mice did not find the platform during the allotted time, they were guided toward it, 
and held for 15 seconds on the platform. Swim time and path length were recorded. 
Following the final session, the platform was removed for a probe trial to test for 
spatial strategy and retention. During the probe test, mice were allowed to swim 
for 60 seconds without the possibility of escape; the percentage of time spent in 
the quadrant where the platform was previously located was measured. In this 
test, the mutant Nf123aIN/23aIN mice fell behind their wild type counterparts in their 
ability to find a hidden platform upon repeated exposure to the same conditions. 
Additionally, when the hidden platforms were removed, the mutant mice spent less 
time swimming in the region that the platform had been in previous trials [14].
The mutant Nf123aIN/23aIN mice also exhibited impairment in the fear associative 
learning test in a fear conditioning experiment [14]. In this experiment, mice were 
placed in a cage and given a short electric shock after being given an audio cue. 
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After 24 hours, their freezing response times after being placed in the same cage 
and being played the audio cue were measured. The mutant mice showed increased 
freezing times over wild type mice after being placed back within the cage that 
shocks had been given [14]. When this testing was repeated over time, the mutant 
mice showed an inability to extinguish this conditioned response as compared with 
the wild type mice [14].
3. Conclusions and future studies
Our studies have demonstrated that Nf1 exon 23a expression is tightly regulated 
and it plays a key role in controlling Ras signaling and learning behaviors in mice. 
In the brain, when exon 23a inclusion is increased, e.g., as shown in the mutant 
Nf123aIN/23aIN mice, the Ras-GAP function of neurofibromin decreased, leading to 
an increase in pERK1/2 activity, which results in defects in learning and memory 
behaviors.
Given the role of Ras/ERK in many brain functions, it is reasonable to predict 
additional behavioral defects in the mutant Nf123aIN/23aIN mice. For example, 
regulated Ras/ERK signaling is known to modulate circadian as well as depressive 
behaviors [26, 27]. Future experiments can be established to examine such behav-
iors in the mutant mice.
The behavioral defects observed in the mutant Nf123aIN/23aIN mice is very interest-
ing in light of a prior study by Costa and colleagues [28]. In this study, Nf1 exon 23a 
was deleted from the Nf1 gene in mice. These mice also suffered from learning and 
memory impairments. Specifically, similar long-term spatial memory defects were 
observed in these mice in the same Morris water maze test [28]. Without exon 23a, 
these mice should have very low Ras/ERK activity, opposite of our mutant mice. 
However, both mutant mice display the same learning defect. These results lead 
to a tantalizing hypothesis that both isoforms of neurofibromin are required for 
optimal brain functions. Even though isoform 1, the one without exon 23a, is the 
predominant isoform in the brain, its deletion is detrimental. Thus, it appears that 
the potential for this exon to be included is important for normal brain functions. 
Is it possible that the alternative splicing is regulated dynamically so under certain 
physiological conditions exon 23a is included significantly more in certain areas 
of the brain? Give the complex nature of this question, only exquisitely designed 
experiments will reveal the answer.
Lastly, the ratio of neurofibromin isoform 1 and isoform 2 in neuronal tissues 
in NF1 patients has never been examined. It will be interesting to study if the 
ratio changes in patients and if so, how does the change contributes to the disease 
development.
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